Safety and Serum Estradiol Levels in Hormonal Treatments for Vulvovaginal Atrophy in Breast Cancer Survivors: A Systematic Review and Meta-Analysis
This systematic review and meta-analysis examined the safety and serum estradiol levels associated with hormonal treatments for vulvovaginal atrophy (VVA) in breast cancer survivors. The findings indicate that certain hormonal therapies lead to minimal increases in serum estradiol levels, remaining within safe thresholds, and effectively alleviating VVA symptoms such as